Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter S. Galatin
Peter S. Galatin
Stanford University
Medicine
Oblimersen
Anesthesia
Gastroenterology
Refractory
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Distress Screening Through Patient-Reported Outcomes Measurement Information System (PROMIS) at an Academic Cancer Center and Network Site: Implementation of a Hybrid Model.
2021
Organic Process Research & Development
Joel W. Neal
Mohana Roy
Kelly Bugos
Christopher Sharp
Peter S. Galatin
Patricia Falconer
Eben L. Rosenthal
Douglas W. Blayney
Shiva Modaressi
Ashley Robinson
Kavitha Ramchandran
Show All
Source
Cite
Save
Citations (1)
Phase I trial of oblimersen (Genasense®) and gemcitabine in refractory and advanced malignancies
2011
Investigational New Drugs
Peter S. Galatin
Ranjana H. Advani
George A. Fisher
Brian Francisco
Thomas Julian
R. Losa
Marta I. Sierra
Branimir I. Sikic
Show All
Source
Cite
Save
Citations (13)
1